EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Severity of GNAO1 ‐Related Disorder Correlates with Changes in G‐Protein Function

Jana Domínguez-Carral iD, William Grant Ludlam, Mar Junyent Segarra, Montserrat Fornaguera Marti, Sol Balsells, Jordi Muchart iD, Dunja Čokolić Petrović, Iván Espinoza iD, Juan Dario Ortigoza-Escobar iD, Kirill A Martemyanov iD, GNAO1-Study Group

Annals of Neurology · 2023-11 · 94 (5) · 987-1004

DOI: 10.1002/ana.26758 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Neurology, online erschienen am 31.08.2023. Verfasst von Jana Domínguez-Carral und 10 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Unit, Department of Child Neurology, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Movement Disorders, Epilepsy. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

GNAO1 ‐related disorders (OMIM #615473 and #617493), caused by variants in the GNAO1 gene, are characterized by developmental delay or intellectual disability, hypotonia, movement disorders, and epilepsy. Neither a genotype–phenotype correlation nor a clear severity score have been established for this disorder. The objective of this prospective and retrospective observational study was to develop a severity score for GNAO1 ‐related disorders, and to delineate the correlation between the underlying molecular mechanisms and clinical severity.

Methods

A total of 16 individuals with GNAO1 ‐related disorders harboring 12 distinct missense variants, including four novel variants (p.K46R, p.T48I, p.R209P, and p.L235P), were examined with repeated clinical assessments, video‐electroencephalogram monitoring, and brain magnetic resonance imaging. The molecular pathology of each variant was delineated using a molecular deconvoluting platform.

Results

The patients displayed a wide variability in the severity of their symptoms. This heterogeneity was well represented in the GNAO1 ‐related disorders severity score, with a broad range of results. Patients with the same variant had comparable severity scores, indicating that differences in disease profiles are not due to interpatient variability, but rather, to unique disease mechanisms. Moreover, we found a significant correlation between clinical severity scores and molecular mechanisms.

Interpretation

The clinical score proposed here provides further insight into the correlation between pathophysiology and phenotypic severity in GNAO1 ‐related disorders. We found that each variant has a unique profile of clinical phenotypes and pathological molecular mechanisms. These findings will contribute to better understanding GNAO1 ‐related disorders. Additionally, the severity score will facilitate standardization of patients categorization and assessment of response to therapies in development. ANN NEUROL 2023;94:987–1004

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Movement DisordersEpilepsyHumansProspective StudiesMutation, MissenseGTP-Binding ProteinsGTP-Binding Protein alpha Subunits, Gi-Go

Substanzen

GTP-Binding ProteinsGNAO1 protein, humanGTP-Binding Protein alpha Subunits, Gi-Go

Autor:innen und Institutionen

  • Epilepsy Unit, Department of Child Neurology, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Department of Neuroscience, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, University of Florida, Jupiter, FL, USA.
  • Department of Rehabilitation, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Department of Statistics Institut de Recerca Sant Joan de Déu Barcelona, Barcelona, Spain.
  • Department of Pediatric Radiology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Osijek University Hospital Center, Department of Pediatrics, Osijek, Croatia.

ORCID-Profile: Jana Domínguez-Carral, Jordi Muchart, Iván Espinoza, Juan Dario Ortigoza-Escobar, Kirill A Martemyanov

Förderung

  • NINDS NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Domínguez-Carral, J., Ludlam, W. G., Junyent Segarra, M., Fornaguera Marti, M., Balsells, S., Muchart, J., Čokolić Petrović, D., Espinoza, I., Ortigoza-Escobar, J. D., Martemyanov, K. A., & GNAO1-Study Group (2023). Severity of GNAO1 ‐Related Disorder Correlates with Changes in G‐Protein Function. Annals of Neurology, 94(5), 987-1004. https://doi.org/10.1002/ana.26758

Vancouver

Domínguez-Carral J, Ludlam WG, Junyent Segarra M, Fornaguera Marti M, Balsells S, Muchart J, et al. Severity of GNAO1 ‐Related Disorder Correlates with Changes in G‐Protein Function. Annals of Neurology. 2023;94(5):987-1004. doi:10.1002/ana.26758

BibTeX
@article{DomnguezCarral2023,
  author = {Domínguez-Carral, Jana and Ludlam, William Grant and Junyent Segarra, Mar and Fornaguera Marti, Montserrat and Balsells, Sol and Muchart, Jordi and Čokolić Petrović, Dunja and Espinoza, Iván and Ortigoza-Escobar, Juan Dario and Martemyanov, Kirill A and GNAO1-Study Group, GNAO1-Study Group},
  title = {Severity of GNAO1 ‐Related Disorder Correlates with Changes in G‐Protein Function},
  journal = {Annals of Neurology},
  year = {2023},
  volume = {94},
  number = {5},
  pages = {987--1004},
  doi = {10.1002/ana.26758}
}
Kostenlos starten →